Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 03, 2025

Get In Touch

JnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitis Pharma News

JnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitis

  • 01 November 2025
  • 2 days ago

Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitis Pharma News

Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitis

  • 28 October 2025
  • 5 days ago

Zydus bags Health Canada approval for Mesalamine suppositories for active ulcerative proctitis Gastroenterology

Zydus bags Health Canada approval for Mesalamine suppositories for active ulcerative proctitis

  • 25 October 2025
  • 1 week ago

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease Pharma News

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

  • 14 October 2025
  • 2 weeks ago

IBS Patients Face Higher Risk of Developing IBD, suggests study Gastroenterology

IBS Patients Face Higher Risk of Developing IBD, suggests study

  • 10 October 2025
  • 3 weeks ago

FDA Approves Guselkumab as First IL-23 Inhibitor with Both SC and IV Induction Options for UC and CD Gastroenterology

FDA Approves Guselkumab as First IL-23 Inhibitor with Both SC and IV Induction Options for UC and CD

  • 21 September 2025
  • 1 month ago

JnJ Tremfya gets USFDA approval for subcutaneous induction in adults with ulcerative colitis Pharma News

JnJ Tremfya gets USFDA approval for subcutaneous induction in adults with ulcerative colitis

  • 20 September 2025
  • 1 month ago

Intas Pharma Secures CDSCO Panel Approval for Post-Marketing Study of Tacrolimus Enema Pharma News

Intas Pharma Secures CDSCO Panel Approval for Post-Marketing Study of Tacrolimus Enema

  • 17 September 2025
  • 1 month ago

AI analysis of colonoscopy improves assessment of Crohn's disease: Study Gastroenterology

AI analysis of colonoscopy improves assessment of Crohn's disease: Study

  • 15 September 2025
  • 1 month ago

AI analysis of colonoscopy improves assessment of Crohn’s disease Gastroenterology

AI analysis of colonoscopy improves assessment of Crohn’s disease

  • 14 September 2025
  • 1 month ago

Recent News

GLP-1 Receptor Agonists Linked to Lower Risk of Ea...

  • 03 November, 2025

Ketogenic diet may protect against stress experien...

  • 03 November, 2025

STORM-PE Trial: Mechanical Thrombectomy Shows Supe...

  • 03 November, 2025

AIIMS INI CET January 2026 admit cards released

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.